- Folate Binding Protein (FBP) shown to be safe and immunogenic in its Phase 1 trial
- Phase 2a trial expected to initiate by year end
An SEC enforcement action uncovers the deep involvement and brazen misbehavior of biotech CEOs in an illegal stock promotion scheme.
Look for beaten-down stocks that are trading at discounts to the value of their assets. Finding absolute bottoms in stocks is not as important as you may think.
Cramer points to Gilead's pipeline for its problems.